Evaxion Biotech A/S:三年随访结果显示,所有患者均持续保持临床应答,无一例出现肿瘤进展。
Evaxion Biotech A/S:三年随访结果显示,所有患者均持续保持临床应答,无一例出现肿瘤进展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.